BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, February 4, 2026
Home
»
Authors
» Nuala Moran
Nuala Moran
Articles
ARTICLES
E&Y Report: Firms Finding Ways To Thrive In Downturn
June 12, 2002
By
Nuala Moran
CeNeS Divests Test Division As Part Of Restructuring
June 12, 2002
By
Nuala Moran
Stem Cell Research Moves Forward Around The World
June 12, 2002
By
Nuala Moran
Pfizer Rep: Improved Drugs' Benefits Get Poor Accounting
June 11, 2002
By
Nuala Moran
Data Glut Prompting More Deals Between Biotech, IT
June 11, 2002
By
Nuala Moran
Pfizer Rep: Improved Drugs' Benefits Get Poor Accounting
June 11, 2002
By
Nuala Moran
Data Glut Prompting More Deals Between Biotech, IT
June 11, 2002
By
Nuala Moran
UK Body Proposes Criminalizing Misuse Of Genetic Information
June 5, 2002
By
Nuala Moran
Pharmagene Extends Argenta Collaboration, Shifts Focus
June 5, 2002
By
Nuala Moran
Pharmagene Extends Argenta Collaboration, Shifts Focus
June 5, 2002
By
Nuala Moran
View All Articles by Nuala Moran